0001171843-24-001307.txt : 20240312 0001171843-24-001307.hdr.sgml : 20240312 20240312200444 ACCESSION NUMBER: 0001171843-24-001307 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240311 FILED AS OF DATE: 20240312 DATE AS OF CHANGE: 20240312 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Blanchard Cheryl R CENTRAL INDEX KEY: 0001326530 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14027 FILM NUMBER: 24744162 MAIL ADDRESS: STREET 1: C/O ZIMMER, INC. STREET 2: P.O. BOX 708 CITY: WARSAW STATE: IN ZIP: 46580 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anika Therapeutics, Inc. CENTRAL INDEX KEY: 0000898437 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 043145961 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 32 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 BUSINESS PHONE: (781) 457-9000 MAIL ADDRESS: STREET 1: 32 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 FORMER COMPANY: FORMER CONFORMED NAME: ANIKA THERAPEUTICS INC DATE OF NAME CHANGE: 19970114 FORMER COMPANY: FORMER CONFORMED NAME: ANIKA RESEARCH INC DATE OF NAME CHANGE: 19930309 4 1 ownership.xml X0508 4 2024-03-11 0 0000898437 Anika Therapeutics, Inc. ANIK 0001326530 Blanchard Cheryl R 32 WIGGINS AVENUE BEDFORD MA 01730 1 1 0 0 President, CEO, Director 0 Common Stock 2024-03-11 4 M 0 14420 0 A 129614 D Common Stock 2024-03-11 4 F 0 6973 25.42 D 122641 D Common Stock 2024-03-11 4 M 0 20001 0 A 142642 D Common Stock 2024-03-11 4 F 0 6473 25.42 D 136169 D Common Stock 2024-03-11 4 M 0 30059 0 A 166228 D Common Stock 2024-03-11 4 F 0 14534 25.79 D 151694 D Common Stock 11742 I Revocable Trust Restricted Stock Unit 0.00 2024-03-11 4 M 0 14420 0 D Common Stock 14420 0 D Restricted Stock Unit 0.00 2024-03-11 4 M 0 20001 0 D Common Stock 20001 40003 D Restricted Stock Unit 0.00 2024-03-11 4 M 0 30059 0 D Common Stock 30059 30060 D Reflects the third and final vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021. Includes the following shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan: 152 shares purchased on May 12, 2023 and 787 shares purchased on November 14, 2023. Reflects an aggregate of 6,973 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2024. Reflects the closing price of ANIK common stock on March 8, 2024, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations. Reflects the first vesting installment of RSUs granted on March 9, 2023. Reflects an aggregate of 6,473 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2024. Reflects the second vesting installment of RSUs granted on March 11, 2022. Reflects an aggregate of 14,534 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 11, 2024. Reflects the closing price of ANIK common stock on March 11, 2024, the trading day on which the vesting of RSUs gave rise to tax withholding obligations. Consists of shares transferred by Dr. Blanchard to The Cheryl R. Blanchard Amended and Restated Revocable Trust dated December 19, 2014, of which Dr. Blanchard is a beneficiary and the sole trustee. Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022. Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024. Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023. /s/ Cheryl R. Blanchard 2024-03-12